These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24313448)

  • 1. Pneumococcal infection in adults: burden of disease.
    Drijkoningen JJ; Rohde GG
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():45-51. PubMed ID: 24313448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.
    van Werkhoven CH; Huijts SM
    Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
    Weil-Olivier C; Gaillat J
    Vaccine; 2014 Apr; 32(18):2022-6. PubMed ID: 24565755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the burden of pneumococcal disease in adults.
    Blasi F; Mantero M; Santus P; Tarsia P
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():7-14. PubMed ID: 22882668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination.
    Orsi A; Ansaldi F; Trucchi C; Rosselli R; Icardi G
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
    Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
    Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
    Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
    Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time for changes in pneumococcal vaccination of adults?
    Overman MC
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S19-22. PubMed ID: 22086890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N; Micone P; Gentile A
    Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pneumoniae infection: a Canadian perspective.
    Deng X; Church D; Vanderkooi OG; Low DE; Pillai DR
    Expert Rev Anti Infect Ther; 2013 Aug; 11(8):781-91. PubMed ID: 23977934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):189-209. PubMed ID: 19296419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epidemiology and Biostatistics of Pneumococcus.
    Oligbu G; Fry NK; Ladhani SN
    Methods Mol Biol; 2019; 1968():215-224. PubMed ID: 30929218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
    Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
    Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and pneumococcal disease.
    Klugman KP; Madhi SA; Feldman C
    Curr Opin Infect Dis; 2007 Feb; 20(1):11-5. PubMed ID: 17197876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.